Dr. David Solit Discusses the Ethical Issues Surrounding Genomics and Precision Cancer Care

episode

Voices in Bioethics Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

NPR News: 09-18-2026 4AM EDT 5 min · 18 Sep 2026 · NPR News Now

4AM ET 09/18/2026 Newscast 3 min · 18 Sep 2026 · Fox News Hourly Update

The Lowe Job with Grace Alexander 1h 8m · 18 Sep 2026 · Barely Famous

Episode 547 | FOMO 2h 0m · 18 Sep 2026 · New Rory & MAL

Report any issue

Source

Recorded22 Mar 2021

Publishervoicesinbioethics.podcasts.library.columbia.edu ↗

Handlerec:19624294

Show notes

The ethical considerations in tumor and germ line analysis range from clinical decisions to research funding. Dr. Solit of the David Solit Lab at Memorial Sloan Kettering Cancer Center weighs in on the importance of genetic testing to match tumors to existing or new treatments based on the biological composition of the tumor. This episode covers the role and value of genomics and molecularly defined subclasses of cancer. Dr. Solit addresses many of the ethical considerations surrounding access to care, privacy, industry relationships, and fundraising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in